Micronization is a crucial step in the production of topical and transdermal products, and Munit stands as a trusted leader in this specialised field. Our state-of-the-art facilities leverage cutting-edge equipment and meticulously controlled processes to micronize Active Pharmaceutical Ingredients (APIs) and Highly Potent Active Pharmaceutical Ingredients (HPAPIs) into fine powders optimally suited for dermal and transdermal application. Our profound expertise in the micronization process enables us to consistently achieve precise particle size distributions, typically within the critical 1 to 10 micron range. This precision is essential for optimising drug delivery and significantly enhancing dermal absorption.
Our dedicated team of experts ensures that all micronization processes are rigorously conducted in strict adherence to Good Manufacturing Practices (GMP) and other relevant industry regulations. Furthermore, we pride ourselves on offering highly customised solutions, precisely tailored to meet the unique needs of each client and their specific product formulations. Our capabilities extend to processing a wide range of substances, including poorly soluble APIs and HPAPIs.
Beyond these core offerings, micronized particles possess a larger surface area, facilitating faster and more efficient drug delivery to the target site. The improved flow properties of micronized powders also contribute to the final product’s superior consistency and quality. For HPAPIs, we provide specialised containment solutions, guaranteeing comprehensive protection for products, personnel, and the environment from potential hazards. Munit’s unwavering commitment to quality and tailored solutions enhances the efficacy of your products and strengthens our position as a leader in this specialised field.